विवरण

Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients.

Figure 8

Chart

Source Paper

Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.

Nutrients (2022)

PMID: 35631156

DOI: 10.3390/nu14102015

Cite This Figure

![Figure 8: Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients.]()

> Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." *Nutrients*, 2022. PMID: [35631156](https://pubmed.ncbi.nlm.nih.gov/35631156/)

<figure>
  <img src="" alt="Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients." />
  <figcaption>Figure 8. Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients.<br>  Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631156/">35631156</a></figcaption>
</figure>

विवरण

Figure 8

Source Paper

Cite This Figure

संबंधित साक्ष्य